ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Adenosine receptors"

  • Abstract Number: 36 • 2014 ACR/ARHP Annual Meeting

    The Use of Three-Dimensionally Printed β-Tricalcium Phosphate/Hydroxyapatite to Further Understand the Regulation of Adenosine Receptors in Osteoclast Formation and Promotion in Bone Regeneration

    Stephanie Ishack1, Aranzazu Mediero1, John Ricci2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Biomaterials, NYU Dental School, New York, NY, 3NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Bone defects resulting from trauma or infection need timely and effective treatments to restore damaged bone. Using specialized three-dimensional (3-D) printing technology, combined with…
  • Abstract Number: 33 • 2014 ACR/ARHP Annual Meeting

    Stimulation of the Adenosine a2A receptor (A2AR) Regulates the Expression of Netrin1 and Their Receptors (Unc5b, DCC) and Inhibits Osteoclast Differentiation and Inflammatory Bone Destruction

    Aranzazu Mediero1, Bhama Ramkhelawon2, Miguel Perez-Aso3, Kathryn Moore2 and Bruce N. Cronstein4, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Leon H. Charney Division of Cardiology, Department of Medicine,, NYU School of Medicine, New York, NY, 3545 1st Ave., New York University, New York City, NY, 4NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose A variety of molecules mediate communication between osteoclasts and osteoblasts during bone remodeling. Netrin1 is a member of the family of axonal guidance proteins,…
  • Abstract Number: 1851 • 2013 ACR/ARHP Annual Meeting

    Adenosine 2A Receptor Promotes Collagen Production By Human Fibroblasts Via Smad2/3-Independent Pathways Involving Cyclic AMP and AKT

    Miguel Perez-Aso1, Patricia Fernandez2, Aranzazu Mediero3, Edwin SL Chan4 and Bruce N. Cronstein5, 1Department of Translational Medicine, New York University School of Medicine, New York, NY, 2Medicine, National Cancer Institute, NIH, Bethesda, MD, 3Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 4Medicine, New York University School of Medicine, New York, NY, 5Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Activation of Adenosine 2A Receptors (A2AR) promotes fibrosis and collagen synthesis. However, the underlying mechanism by which A2AR stimulate collagen synthesis is still unclear. …
  • Abstract Number: 1830 • 2013 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor (A2AR) Diminishes Wear Particle (UHMWPE)-Mediated Osteolysis, Increases Bone Formation and Regulates Expression Of Axonal Guidance Proteins (AGP) By Macrophages, Osteoclasts (OC) and Osteoblasts (OB)

    Aranzazu Mediero1, Tuere Wilder2, Miguel Perez-Aso3 and Bruce N. Cronstein4, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3Department of Translational Medicine, New York University School of Medicine, New York, NY, 4Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Communication between OC and OB is critical for maintenance of bone homeostasis; both OC and OB release regulatory messengers. Among these signaling molecules are…
  • Abstract Number: 1838 • 2013 ACR/ARHP Annual Meeting

    The Use Of Three-Dimensionally Printed β-Tricalcium Phosphate/Hydroxyapatite To Understand The Regulation Of Adenosine Receptors In Osteoclast Formation and Promotion In Bone Regeneration

    Stephanie Ishack1, Aranzazu Mediero1, Tuere Wilder2, John Ricci3 and Bruce N. Cronstein4, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3Biomaterials, NYU Dental School, New York, NY, 4Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Bone defects resulting from trauma or infection need timely and effective treatments to replace damaged bone. Using specialized three-dimensional (3-D) printing technology, combined with…
  • Abstract Number: 935 • 2013 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor Activates The Pro-Fibrotic Wnt / β-Catenin Signaling In Human Dermal Fibroblasts

    Miguel Perez-Aso1 and Bruce N. Cronstein2, 1Department of Translational Medicine, New York University School of Medicine, New York, NY, 2Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Upon adenosine formation in stress conditions, the adenosine A2A Receptor (A2AR) activation promotes wound healing, but it is also detrimental in fibrotic conditions such…
  • Abstract Number: 53 • 2013 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor As a Potential New Therapeutic Target For The Prevention/Treatment Of Osteoarthritis

    Aranzazu Mediero1, Tuere Wilder2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Osteoarthritis, the most common type of arthritis in the United States, results from trauma and other mechanical factors as well as metabolic changes in…
  • Abstract Number: 2570 • 2013 ACR/ARHP Annual Meeting

    Tenofovir But Not Adefovir Prevents Liver and Skin Fibrosis In Two Models Of Adenosine-Mediated Injury

    Jessica L. Feig1, Doreen Tivon2, Miguel perez Aso3, Timothy Cardozo2 and Bruce N. Cronstein4, 1Medicine. Department of Translational Medicine, New York University School of Medicine, New York, NY, 2Department of Translational Medicine, New York University School of Medicine, New York, NY, 3NYU Univ Medical Center, New York, NY, 4Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Acyclic nucleoside phosphonates are a key class of antivirals commonly used in the treatment of both DNA and retroviral infections.  Adefovir and tenofovir are…
  • Abstract Number: 2222 • 2013 ACR/ARHP Annual Meeting

    Positive Allosteric Modulation Of The Adenosine A2a Receptor Alters Inflammatory Cytokine Production and Alleviates Chronic Arthritis In Rats

    Ajith A. Welihinda, Jordan A. Mechanic and Edward P. Amento, Molecular Medicine Research Institute, Sunnyvale, CA

    Background/Purpose: Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by inflammation and joint destruction; a consequence of which is the high local concentration of…
  • Abstract Number: 2516 • 2012 ACR/ARHP Annual Meeting

    Adenosine Receptors Stimulate Bone Regeneration by Targeting Osteoclasts

    Aranzazu Mediero1, Tuere Wilder2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Various types of orthopedic procedures, including spinal fusion and repair of bone defects due to trauma, infection or metastatic disease, require formation of new…
  • Abstract Number: 1965 • 2012 ACR/ARHP Annual Meeting

    Adenosine Regulates Bone Metabolism Via A1, A2A and A2B Receptors in Bone Marrow Cells From Normal and Patients with Multiple Myeloma

    Wenjie He1, Amitabha Mazumder2 and Bruce N. Cronstein3, 1Dept of Med, Div of Rheum, NYU, New York, NY, 2NYU Cancer Center, New York, NY, 3Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Multiple myeloma is a haematologic malignancy that is characterized by osteolytic bone lesions, wherein coupled bone remodeling is disrupted with increased osteoclast activation and…
  • Abstract Number: 1805 • 2012 ACR/ARHP Annual Meeting

    The Pro-Fibrotic Cytokines IL-33 and IL-13 Modulates Dermal Fibrosis Via the A2A Adenosine Receptor

    Ross C. Radusky1, Jessica L. Feig2, Bruce N. Cronstein3, Andrew G. Franks Jr.4 and Edwin SL Chan1, 1Medicine, New York University School of Medicine, New York, NY, 2Medicine. Department of Translational Medicine, New York University School of Medicine, New York, NY, 3Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY, 4Dermatology & Medicine (Rheumatology), New York University, New York, NY

    Background/Purpose: We have previously demonstrated that the nucleoside adenosine mediates collagen production and induce dermal fibrosis in in vitro and in vivo models. IL–13 expression…
  • Abstract Number: 1778 • 2012 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor (A2AR) Activation Stimulates Increased Expression of Collagen-1 and Collagen-3 by Different Signaling Pathways in Normal Human Dermal Fibroblasts

    Miguel Perez Aso1 and Bruce N. Cronstein2, 1NYU Univ Medical Center, New York, NY, 2Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Pathological fibrosis in the skin and other organs is the hallmark of scleroderma and other fibrosing diseases.  Adenosine, acting at A2AR, plays a critical…
  • Abstract Number: 15 • 2012 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor Stimulation Inhibits OC Formation by Suppressing NFkB Translocation to the Nucleus by A PKA-ERK1/2 Mediated Mechanism

    Aranzazu Mediero1 and Bruce N. Cronstein2, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Adenosine, a nucleoside released at sites of injury and hypoxia, mediates its effects via activation of G-protein-coupled receptors (A1, A2A, A2B, A3). Previously we…
  • Abstract Number: 16 • 2012 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor Diminishes Bone Destruction At Inflamed Sites, in Part, Via Downregulating Semaphorin4D-PlexinB1 Communication Between Osteoclasts and Osteoblasts

    Aranzazu Mediero1 and Bruce N. Cronstein2, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Communication between osteoclasts and osteoblasts is essential for bone homeostasis. Semaphorin4D (Sema4D), expressed on the surface of and secreted by osteoclasts, macrophages and T…
  • « Previous Page
  • 1
  • 2
  • 3
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology